EvidentIQ Q&A
Dacima has joined the EvidentIQ Group, you can read the complete announcement here. General Q01 When did the change become effective? A01 July 1, 2022.... Read More
Dacima has joined the EvidentIQ Group
We are pleased to announce that Dacima has joined the EvidentIQ Group, a German based end-to-end eClinical solutions company with a broad data science service... Read More
Happy Holidays
DACIMA team wishes you a happy holiday and healthy New Year! The past year has not been easy for everyone. We are so grateful for... Read More
Results of COLCORONA study on ways to prevent morbidity and mortality related to COVID-19
Today the Montreal Heart Institute (MHI) announced an important step in the fight against the COVID-19 pandemic, by making public the results of its COLCORONA... Read More
Movember to Launch World’s First Cancer Registry ‘Super Network’
MOVEMBER is launching the world’s largest network of prostate cancer patient registries which will have the power to transform treatment and care of the disease... Read More
Coronavirus outbreak and potential impact on clinical data
DACIMA is committed to providing assistance to governments, CROs, sponsors, for all their data collected needs for the COVID-19 pandemic. Since Coronavirus outbreak, Dacima has... Read More
DACIMA providing randomization (IWRS), supply management and drug accountability software for the COLCORONA trial on COVID-19
Dacima is pleased to announce that our web randomization (IWRS), supply management and drug accountability modules of our Electronic Data Capture software, Dacima Clinical Suite,... Read More
Dacima at HIMSS20
Dacima will participate in HIMSS20 in Orlando Florida from March 9-13, 2020. Visit us at booth #3829 to learn more about Dacima Clinical Suite which... Read More
We have moved!
Due to continued growth, Dacima is thrilled to announce that we have moved our head office to a new larger office space. If you are... Read More
